Outcomes of Continuation vs Discontinuation of Adalimumab Therapy During Third Trimester of Pregnancy in Inflammatory Bowel Disease

Brindusa Truta, Joseph K. Canner, Sandy H. Fang, Jonathan E. Efron, Bashar Safar

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Outcomes of Continuation vs Discontinuation of Adalimumab Therapy During Third Trimester of Pregnancy in Inflammatory Bowel Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences